Accounts Receivables - vTv Therapeutics Inc (NASDAQ:VTVT) - Alpha Spread

vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 14.93 USD 6.41% Market Closed
Market Cap: 36.3m USD
Have any thoughts about
vTv Therapeutics Inc?
Write Note

vTv Therapeutics Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

vTv Therapeutics Inc
Accounts Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
vTv Therapeutics Inc
NASDAQ:VTVT
Accounts Receivables
$306k
CAGR 3-Years
N/A
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Receivables
$11.7B
CAGR 3-Years
6%
CAGR 5-Years
16%
CAGR 10-Years
12%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Receivables
$4.7B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Accounts Receivables
$6.9B
CAGR 3-Years
16%
CAGR 5-Years
13%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Receivables
$1.7B
CAGR 3-Years
21%
CAGR 5-Years
29%
CAGR 10-Years
35%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Receivables
$5.7B
CAGR 3-Years
-7%
CAGR 5-Years
18%
CAGR 10-Years
20%

See Also

What is vTv Therapeutics Inc's Accounts Receivables?
Accounts Receivables
306k USD

Based on the financial report for Jun 30, 2024, vTv Therapeutics Inc's Accounts Receivables amounts to 306k USD.

What is vTv Therapeutics Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
-30%

Back to Top